These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 33788775)

  • 1. Identification of Substandard and Falsified Medicines: Influence of Different Tolerance Limits and Use of Authenticity Inquiries.
    Hauk C; Hagen N; Heide L
    Am J Trop Med Hyg; 2021 Mar; 104(5):1936-1945. PubMed ID: 33788775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surveillance for falsified and substandard medicines in Africa and Asia by local organizations using the low-cost GPHF Minilab.
    Petersen A; Held N; Heide L;
    PLoS One; 2017; 12(9):e0184165. PubMed ID: 28877208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substandard and Falsified Antibiotics and Medicines against Noncommunicable Diseases in Western Cameroon and Northeastern Democratic Republic of Congo.
    Schäfermann S; Hauk C; Wemakor E; Neci R; Mutombo G; Ngah Ndze E; Cletus T; Nyaah F; Pattinora M; Wistuba D; Helmle I; Häfele-Abah C; Gross H; Heide L
    Am J Trop Med Hyg; 2020 Aug; 103(2):894-908. PubMed ID: 32394884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low Prevalence of Substandard and Falsified Antimalarial and Antibiotic Medicines in Public and Faith-Based Health Facilities of Southern Malawi.
    Khuluza F; Kigera S; Heide L
    Am J Trop Med Hyg; 2017 May; 96(5):1124-1135. PubMed ID: 28219993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fighting trafficking of falsified and substandard medicinal products in Russia.
    Fayzrakhmanov NF
    Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and Estimated Economic Burden of Substandard and Falsified Medicines in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis.
    Ozawa S; Evans DR; Bessias S; Haynie DG; Yemeke TT; Laing SK; Herrington JE
    JAMA Netw Open; 2018 Aug; 1(4):e181662. PubMed ID: 30646106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substandard and Falsified Medicines: Proposed Methods for Case Finding and Sentinel Surveillance.
    Pisani E; Hasnida A; Rahmi M; Kok MO; Harsono S; Anggriani Y
    JMIR Public Health Surveill; 2021 Aug; 7(8):e29309. PubMed ID: 34181563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of medicines in southern Togo: Investigation of antibiotics and of medicines for non-communicable diseases from pharmacies and informal vendors.
    Schäfermann S; Wemakor E; Hauk C; Heide L
    PLoS One; 2018; 13(11):e0207911. PubMed ID: 30496234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cross-sectional analysis of falsified, counterfeit and substandard medicines in a low-middle income country.
    Khurelbat D; Dorj G; Sunderland B; Sanjjav T; Bayarsaikhan E; Damdinjav D; Dorj G; Jigjidsuren A; Lkhagvasuren O; Erdenetsetseg B
    BMC Public Health; 2020 May; 20(1):743. PubMed ID: 32434489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Research on the Development of Methods for Detection of Substandard and Falsified Medicines by Clarifying Their Pharmaceutical Characteristics Using Modern Technology.
    Yoshida N
    Biol Pharm Bull; 2024; 47(5):878-885. PubMed ID: 38692863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterizing Medicine Quality by Active Pharmaceutical Ingredient Levels: A Systematic Review and Meta-Analysis across Low- and Middle-Income Countries.
    Ozawa S; Chen HH; Lee YA; Higgins CR; Yemeke TT
    Am J Trop Med Hyg; 2022 Jun; 106(6):1778-1790. PubMed ID: 35895431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A New Handheld Device for the Detection of Falsified Medicines: Demonstration on Falsified Artemisinin-Based Therapies from the Field.
    Wilson BK; Kaur H; Allan EL; Lozama A; Bell D
    Am J Trop Med Hyg; 2017 May; 96(5):1117-1123. PubMed ID: 28219992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Cross-Sectional Investigation of the Quality of Selected Medicines for Noncommunicable Diseases in Private Community Drug Outlets in Cambodia during 2011-2013.
    Rahman MS; Yoshida N; Tsuboi H; Sokchamroeun U; Keila T; Sovannarith T; Kiet HB; Dararath E; Akimoto Y; Tanimoto T; Kimura K
    Am J Trop Med Hyg; 2019 Nov; 101(5):1018-1026. PubMed ID: 31516106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Public health interventions to protect against falsified medicines: a systematic review of international, national and local policies.
    Hamilton WL; Doyle C; Halliwell-Ewen M; Lambert G
    Health Policy Plan; 2016 Dec; 31(10):1448-1466. PubMed ID: 27311827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substandard and Falsified Medicines in Myanmar.
    Sakuda M; Yoshida N; Takaoka T; Sanada T; Rahman MS; Tanimoto T; Zin T; Kimura K; Tsuboi H
    Pharmacy (Basel); 2020 Mar; 8(1):. PubMed ID: 32204459
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of thin-layer chromatography to detect counterfeit sulfadoxine/pyrimethamine tablets with the wrong active ingredient in Malawi.
    Khuluza F; Kigera S; Jähnke RW; Heide L
    Malar J; 2016 Apr; 15():215. PubMed ID: 27075749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Point-of-Care Anti-Counterfeit Medicines Technologies: Awareness and Utilization among Medical Practitioners in Eastern Nigeria.
    Iloh GU; Akodu BA; Emeka EA; Obi IV
    West Afr J Med; 2021 Nov; Vol. 38(11):1029-1035. PubMed ID: 34918894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substandard and falsified anti-tuberculosis drugs: a preliminary field analysis.
    Bate R; Jensen P; Hess K; Mooney L; Milligan J
    Int J Tuberc Lung Dis; 2013 Mar; 17(3):308-11. PubMed ID: 23321423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of the effectiveness of the CD3+ tool to detect counterfeit and substandard anti-malarials.
    Batson JS; Bempong DK; Lukulay PH; Ranieri N; Satzger RD; Verbois L
    Malar J; 2016 Feb; 15():119. PubMed ID: 26917250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mind the gaps--the epidemiology of poor-quality anti-malarials in the malarious world--analysis of the WorldWide Antimalarial Resistance Network database.
    Tabernero P; Fernández FM; Green M; Guerin PJ; Newton PN
    Malar J; 2014 Apr; 13():139. PubMed ID: 24712972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.